Absci Corporation (NASDAQ:ABSI) shares surged 24% on Wednesday after the biotechnology company reported encouraging interim ...

HHS announced a sweeping effort aimed at strengthening America's role in clinical research, accelerating the development of ...

CalciMedica, Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...

WASHINGTON - The Department of Health and Human Services launched a department-wide initiative this week aimed at accelerating clinical research as federal health officials seek to strengthen the ...

The FDA’s efforts are meant to reduce phase 1 timelines by six to 12 months, Diamantas said. They include what he called an ...

Thermo Fisher Scientific, the world leader in serving science, will showcase new capabilities, strategic investments and initiatives at BIO International 2026 that are helping pharma and biotech ...

Parexel, a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the launch of the Parexel ...

HHS Secretary Robert F. Kennedy Jr. wants to speed up clinical trials in the United States.“A recent study found that China ...

VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded its laboratory ...

SILVIA-Powered SASI Benchmark Published by TrialSite News Identifies Disclosure Risk as Greater Systemic Challenge Than ...

Kalaris Therapeutics, Inc. (Nasdaq: KLRS) ('Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today ...

The Food and Drug Administration (FDA) on Monday launched a new initiative to speed up early-stage clinical trials as part of ...